Cargando…
Calcitriol exerts an anti‐tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response
Osteosarcoma is the most common type of primary bone tumor, and novel therapeutic approaches for this disease are urgently required. To identify effective agents, we screened a panel of Food and Drug Administration (FDA)‐approved drugs in AXT cells, our newly established mouse osteosarcoma line, and...
Autores principales: | Shimizu, Takatsune, Kamel, Walied A., Yamaguchi‐Iwai, Sayaka, Fukuchi, Yumi, Muto, Akihiro, Saya, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581526/ https://www.ncbi.nlm.nih.gov/pubmed/28643892 http://dx.doi.org/10.1111/cas.13304 |
Ejemplares similares
-
Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo
por: Shimizu, Takatsune, et al.
Publicado: (2022) -
Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells
por: Ueki, Arisa, et al.
Publicado: (2012) -
Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells
por: Yamaguchi, Sayaka I, et al.
Publicado: (2015) -
Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation
por: Lin, Yu-Min, et al.
Publicado: (2018) -
Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma
por: Zhu, Peijun, et al.
Publicado: (2022)